lifearc1 Profile Banner
LifeArc Profile
LifeArc

@lifearc1

Followers
8K
Following
3K
Statuses
3K

Medical research non-profit transforming promising life science ideas into medical breakthroughs that change patients’ lives.

Stevenage, London, Edinburgh
Joined February 2009
Don't wanna be here? Send us removal request.
@lifearc1
LifeArc
23 hours
The agenda for the Translational Science Summit on MND and Rare Dementias is live! Join us for sessions led by experts in neurodegeneration research. #RareNeuro
Tweet media one
0
2
3
@lifearc1
LifeArc
4 days
What drives you to do your best at work? Hear from our team about what keeps them motivated and makes them proud to be part of LifeArc. If you're interested in being part of our team, see our careers page:
0
0
2
@lifearc1
LifeArc
11 days
The bronchiectasis sector is rapidly expanding. New insights project the market will reach $766.7 million by 2035, highlighting the urgent need to invest in solutions to improve outcomes. Learn more about bronchiectasis here:
Tweet media one
0
1
8
@lifearc1
LifeArc
13 days
We need to work together to translate discoveries into tangible therapies for people with rare diseases. This network of 4 Translational Centres for Rare Diseases will support the development of new tests, treatments and hopefully cures.
0
5
4
@lifearc1
LifeArc
14 days
We can help transform your research into new treatments and diagnostics! 💡 Explore our capabilities: 🔬 Therapeutics 🔬 Supporting functions and technologies
Tweet media one
0
1
3
@lifearc1
LifeArc
15 days
Find out more:
0
0
2
@lifearc1
LifeArc
15 days
Last chance to vote for our film in the Smiley Charity Film Awards! In this clip, Victor shares his journey with learning to live with emphysema. Let’s drive awareness and improve care—vote now! 👉 @asthmalunguk @SmileyCFA
0
2
3
@lifearc1
LifeArc
18 days
Keytruda® represents a significant breakthrough in cancer research and is one of the success stories we're most proud of, having humanised the antibody for this best-selling drug. Here's a snapshot of Keytruda®'s translational journey!
Tweet media one
0
1
3
@lifearc1
LifeArc
20 days
Join us in person for the LifeArc Translational Science Summit on MND and Rare Dementias! 🌟 Learn about the latest research, connect with industry experts, and shape the future of neurodegenerative disease research. Register for free - #RareNeuro
Tweet media one
0
4
0
@lifearc1
LifeArc
21 days
Watch the NeurEYE Video:
0
0
0
@lifearc1
LifeArc
25 days
📢Our funding team is hiring! Responsible for scoping, delivering, and managing our translational grant funding initiatives, the team maximises the impact of the science we support. Apply now:
Tweet media one
Tweet media two
0
3
2
@lifearc1
LifeArc
26 days
We need your vote! Our film about living with lung conditions is nominated for the Smiley Charity Film Awards! In this clip, Bryony shares her asthma journey. Vote for us: 👉 @asthmalunguk @SmileyCFA
0
5
5
@lifearc1
LifeArc
28 days
Today we're announcing we are working with @ClevelandClinic - one of the largest healthcare researchers in the world - on a 10-year master services agreement to develop new monoclonal antibody treatments for patients with high unmet medical needs:
Tweet media one
0
4
8
@lifearc1
LifeArc
29 days
RT @CR_Horizons: 🚀 Got a #ChildhoodCancer research project? Learn about the #CFurther initiative in our webinar including how to submit yo…
0
1
0
@lifearc1
LifeArc
1 month
Partnering with us on antibody discovery can significantly improve quality and enhance your project's chances of success. Find out more and get in touch to partner with us: 
Tweet media one
0
0
2
@lifearc1
LifeArc
1 month
Our Chief Project and Portfolio Officer, Karen Skinner, and Chief Medical Officer, Jonathan Morgan, were invited to The White House yesterday to participate in a panel at the #WhiteHouseCGT forum.
Tweet media one
Tweet media two
Tweet media three
0
2
4
@lifearc1
LifeArc
1 month
We convened experts in the MND biomarker community to discuss pressing challenges and prioritise solutions. 📄 Read our findings: 💬 Have your say by ranking top priorities: 
Tweet media one
0
2
1
@lifearc1
LifeArc
1 month
Last call for our £3 million drug repurposing funding for chronic respiratory infections! Closing 15 January. We're funding translational studies, from proof of concept to clinical trials, aiming to accelerate existing drugs towards patient benefit:
Tweet media one
0
0
0